Filing Flows › Connect Biopharma Holdings (CNTB) › Q1 2026
Connect Biopharma Holdings (CNTB) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 12, 2026
Connect Biopharma Holdings (CNTB) reported revenue of $169K for the first quarter 2026 (Q1 2026).
Connect Biopharma Holdings, Q1 2026: revenue $169K, net loss $19.4M, operating cash flow −$16.0M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $169K | — | — |
| Operating profit | −$19.6M | — | — |
| Net earnings | −$19.4M | — | — |
| Operating cash flow | −$16.0M | — | — |
What changed
Revenue was $169K in Q1 2026.
Operating costs exceeded revenue by $19.6M, an operating margin of -11601.8%. The quarter ended with a net loss of $19.4M.
Operating cash flow was −$16.0M. Non-cash charges added back $164K of depreciation and amortization and $1.2M of share-based compensation. Working capital and other items added $2.0M.
Questions
What was Connect Biopharma Holdings' revenue in the first quarter 2026?
Connect Biopharma Holdings (CNTB) reported revenue of $169K for the first quarter 2026 (Q1 2026).